Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
RCKT
ROCKET PHARMACEUTICALS, INC.
NASDAQ · Pharmaceutical Preparations
Last close
$2.63
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$288.71M
RECENT INSIDER TRADES
2026-09-15
· Wilson Martin
(General Counsel)
· SELL
2026-08-20
· Shah Gaurav
(CEO)
· SELL
2026-08-20
· Wilson Martin
(General Counsel)
· SELL
2026-08-17
· Shah Gaurav
(CEO)
· SELL
2026-08-17
· Wilson Martin
(General Counsel)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
195
Shares held
119,361,819
Value
$561.09M
Percent of shares outstanding
108.73%
As of quarter end
2026-06-30
RECENT NEWS
Goldman Sachs upgrades Rocket Pharmaceuticals rating on Danon disease drug progress
Cantor Fitzgerald reiterates Rocket Pharmaceuticals stock rating
Rocket Pharmaceuticals updates Danon disease program with RP-A501 pivotal trial data
Rocket Pharmaceuticals secures $150M credit facility
Rocket Pharmaceuticals general counsel sells $256,463 in shares
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ROCKET PHARMACEUTICALS, INC. (RCKT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit